{"id":"W2122024610","doi":"10.1517/13543784.13.4.403","title":"Ximelagatran: the first oral direct thrombin inhibitor","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Ximelagatran; Direct thrombin inhibitor; Medicine; Discovery and development of direct thrombin inhibitors; Coagulation; Anticoagulant; Thrombin; Intensive care medicine; Warfarin; Pharmacology; Atrial fibrillation; Dabigatran; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002445816,0.0008032531,0.001155582,0.00171596,0.0002369647,0.0009464168,0.0006202683,0.001183745,0.007030978],"category_scores_gemma":[0.000375818,0.0001811984,0.0003380756,0.001753618,0.0002823023,0.0009404626,0.0004073595,0.0009191827,0.006692264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005031746,"about_ca_system_score_gemma":0.001031276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009159523,"about_ca_topic_score_gemma":0.001284168,"domain_scores_codex":[0.9998236,0.00002371996,0.00002007808,0.00002876999,0.00008501462,0.00001884674],"domain_scores_gemma":[0.9998888,0.00003207399,0.00002866292,0.000004605531,0.00002810861,0.00001780645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009422496,0.00006495824,0.0002077173,0.01016393,0.00004923759,0.0005908431,0.00004162944,0.000121279,0.00284941,0.001459188,0.03551058,0.9488469],"study_design_scores_gemma":[0.0000392532,0.00010617,0.000794506,0.001861209,0.00006883412,0.004060621,0.00002651169,0.00003257807,0.00113167,0.000634548,0.9912351,0.000008966303],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002481163,0.9951775,0.0001365816,0.0003998207,0.0002936672,0.000009755236,0.00003195292,0.00001750827,0.003685093],"genre_scores_gemma":[0.001718396,0.9936277,0.0002413841,0.0003555656,0.0002845814,0.00001017351,0.00005134554,0.000002445068,0.00370853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007030978,"threshold_uncertainty_score":0.02352095,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1352479400011735,"score_gpt":0.3960961936146366,"score_spread":0.2608482536134631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}